Prevention with a drop of blood?

The cancerous tumour releases DNA (cDNA) into the bloodstream, which is proving to be a biological source of cancer analysis and a diagnostic tool with great potential (detection of residual disease, monitoring of treatment efficacy and identification of resistance mechanisms, monitoring of recurrence and possibly screening). Alain Thierry and his team are among those who have made the greatest contribution to demonstrating the validity and clinical utility of cirDNA. Preventing cancer at any stage by simply analysing drops of blood looks set to become a reality.

Hosted by:

 

Pr Etienne Minvielle

Professor at the Ecole Polytechnique, CNRS Research Director, Gustave Roussy public health doctor

 Speaker:

Alain Thierry

Inserm Research Director, founder of the liquid biopsy start-up DiaDx SAS, Montpellier Cancer Institute

 

Sandrine Boucher


 

Unicancer Director of Medical Strategy and Performance, 
 

 Jean-Louis Mergny